Cardiovascular health in pediatric patients with X-linked hypophosphatemia under two years of burosumab therapy

IntroductionX-linked hypophosphatemia (XLH) is caused by an inactivating mutation in the phosphate-regulating endopeptidase X-linked (PHEX) gene whose defective product fails to control phosphatonin fibroblast growth factor 23 (FGF23) serum levels. Although elevated FGF23 levels have been linked wit...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Avivit Brener, Roxana Cleper, Guy Baruch, Ehud Rothschild, Michal Yackobovitch-Gavan, Gil Beer, Leonid Zeitlin, Livia Kapusta
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2024-05-01
coleção:	Frontiers in Endocrinology
Assuntos:	cardiac function echocardiogram elevated blood pressure FGF23 left ventricular hypertrophy X-linked hypophosphatemia
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fendo.2024.1400273/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!